Clinical significance of bax/bcl-2 ratio in chronic lymphocytic leukemia.
about
Expression of Apoptosis-regulating Proteins Bcl-2 and Bax in Lymph Node Aspirates from Dogs with Lymphoma.Combined Treatment with Stattic and Docetaxel Alters the Bax/Bcl-2 Gene Expression Ratio in Human Prostate Cancer CellsQuaDMutEx: quadratic driver mutation explorerThe molecular mechanism of treating osteoarthritis with dipsacus saponins by inhibiting chondrocyte apoptosis.Systems modeling accurately predicts responses to genotoxic agents and their synergism with BCL-2 inhibitors in triple negative breast cancer cells.Chlorogenic acid regulates apoptosis and stem cell marker-related gene expression in A549 human lung cancer cells.
P2860
Clinical significance of bax/bcl-2 ratio in chronic lymphocytic leukemia.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年学术文章
@wuu
2015年学术文章
@zh-cn
2015年学术文章
@zh-hans
2015年学术文章
@zh-my
2015年学术文章
@zh-sg
2015年學術文章
@yue
2015年學術文章
@zh
2015年學術文章
@zh-hant
name
Clinical significance of bax/bcl-2 ratio in chronic lymphocytic leukemia.
@ast
Clinical significance of bax/bcl-2 ratio in chronic lymphocytic leukemia.
@en
type
label
Clinical significance of bax/bcl-2 ratio in chronic lymphocytic leukemia.
@ast
Clinical significance of bax/bcl-2 ratio in chronic lymphocytic leukemia.
@en
prefLabel
Clinical significance of bax/bcl-2 ratio in chronic lymphocytic leukemia.
@ast
Clinical significance of bax/bcl-2 ratio in chronic lymphocytic leukemia.
@en
P2093
P2860
P50
P1433
P1476
Clinical significance of bax/bcl-2 ratio in chronic lymphocytic leukemia.
@en
P2093
Davide Rossi
Francesca Maria Rossi
Giovanna De Santis
Giovanni Del Poeta
Luca Maurillo
Maria Ilaria Del Principe
Mariagiovanna Cefalo
Sergio Amadori
Tamara Bittolo
P2860
P356
10.3324/HAEMATOL.2015.131854
P50
P577
2015-11-12T00:00:00Z